tradingkey.logo

Profound Medical Corp <PRN.TO> expected to post a loss of 35 cents a share - Earnings Preview

ReutersMar 4, 2025 9:37 PM
  • Profound Medical Corp PRN.TO is expected to show a rise in quarterly revenue when it reports results on March 6 for the period ending December 31 2024

  • The Mississauga Ontario-based company is expected to report a 112.4% increase in revenue to $4.267 million from $2.01 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Profound Medical Corp is for a loss of 35 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Profound Medical Corp is C$24.42​, above​ its last closing price of C$10.11. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.29

-0.29

-0.38

Missed

-29.9

Jun. 30 2024

-0.29

-0.29

-0.28

Beat

4.1

Mar. 31 2024

-0.28

-0.27

-0.26

Beat

5.5​

Dec. 31 2023

-0.28

-0.32

-0.42

Missed

-31.5

​​Sep. 30 2023

-0.33

-0.34

-0.26

Beat

22.7

Jun. 30 2023

-0.36

-0.35

-0.35

Met

1.4​

Mar. 31 2023

-0.35

-0.36

-0.32

Beat

11.1

Dec. 31 2022

-0.37

-0.46

Missed

-24.3

This summary was machine generated March 4 at 21:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI